Hepatitis C Drug Sofosbuvir in Combination with Other Antivirals Safe for Covid-19: Report
Top Stories

Hepatitis C Drug Sofosbuvir in Combination with Other Antivirals Safe for Covid-19: Report

Hepatitis C Drug Sofosbuvir in Combination with Other Antivirals Safe for Covid-19: Report
The results, published in the journal Scientific Reports, support the use of the USFDA-approved hepatitis C drug EPCLUSA — Sofosbuvir/Velpatasvir — in combination with other antiviral drugs in Covid-19 clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *